Should reducing nocturnal blood pressure be a therapeutic target in CKD? The time is ripe for a clinical outcomes trial

Am J Kidney Dis. 2007 Dec;50(6):901-3. doi: 10.1053/j.ajkd.2007.10.005.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Administration, Oral
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Blood Pressure / physiology*
  • Blood Pressure Monitoring, Ambulatory
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / physiopathology
  • Chronic Disease
  • Circadian Rhythm / physiology*
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy
  • Hypertension / etiology
  • Kidney Diseases / complications
  • Kidney Diseases / physiopathology*

Substances

  • Antihypertensive Agents